These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [MPTP and Parkinson's disease]. Imai H No To Shinkei; 1988 Nov; 40(11):1011-24. PubMed ID: 3064783 [No Abstract] [Full Text] [Related]
10. [Experimental model of Parkinson disease induced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Renkawek K Neuropatol Pol; 1986; 24(1):1-8. PubMed ID: 3489205 [No Abstract] [Full Text] [Related]
11. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D; Gross C; Lebrun-Grandié P; Bioulac B C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601 [TBL] [Abstract][Full Text] [Related]
12. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135 [TBL] [Abstract][Full Text] [Related]
13. Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. Wright JM; Wall RA; Perry TL; Paty DW N Engl J Med; 1984 Feb; 310(5):325. PubMed ID: 6606784 [No Abstract] [Full Text] [Related]
15. MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study. Doudet D; Gross C; Lebrun-Grandie P; Bioulac B Brain Res; 1985 May; 335(1):194-9. PubMed ID: 3873977 [TBL] [Abstract][Full Text] [Related]
16. Changes in the local cerebral metabolic rate for glucose in the MPTP primate model of Parkinson's disease. Schwartzman RJ; Alexander GM Adv Neurol; 1987; 45():171-3. PubMed ID: 3493624 [No Abstract] [Full Text] [Related]
17. Monkey model of Parkinson's disease. Kolata G Science; 1983 May; 220(4598):705. PubMed ID: 6403987 [No Abstract] [Full Text] [Related]
18. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P; Marsden CD J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760 [TBL] [Abstract][Full Text] [Related]